Human tumor antigen-specific T lymphocytes and interleukin-2-activated natural killer cells: Comparisons of antitumor effects in vitro and in vivo

Clinical Cancer Research

Volumn 4, Issue 5, 1998, Pages 1135-1145

  Whiteside, Theresa L ^a,b   Sung, Myung Whun ^a,b   Nagashima, Shigeki ^b   Chikamatsu, Kazuaki ^b   Okada, Kazuhiko ^b   Vujanovic, Nikola L ^a,b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; DNA FRAGMENT; HLA A2 ANTIGEN; INTERLEUKIN 2; MAJOR HISTOCOMPATIBILITY ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; THYMIDINE; TRITIUM; TUMOR ANTIGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CELL SUSPENSION; CONTROLLED STUDY; CYTOLYSIS; EFFECTOR CELL; FEMALE; HEAD AND NECK CARCINOMA; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MAJOR HISTOCOMPATIBILITY COMPLEX RESTRICTION; MOUSE; NATURAL KILLER CELL; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; SPHEROID CELL; T LYMPHOCYTE; TUMOR XENOGRAFT;

ANIMALS; CARCINOMA, SQUAMOUS CELL; HEAD AND NECK NEOPLASMS; HUMANS; IMMUNOTHERAPY, ADOPTIVE; INTERLEUKIN-2; KILLER CELLS, LYMPHOKINE-ACTIVATED; LYMPHOCYTES, TUMOR-INFILTRATING; MICE; MICE, NUDE; SPHEROIDS, CELLULAR; TUMOR CELLS, CULTURED;

EID: 0031896593     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Whiteside, T. L., and Herberman, R. B. Role of human natural killer cells in health and disease. Clin. Diag. Lab. Immunol., 1: 125-133, 1994.
2. Trinchieri, G. Biology of natural killer cells. Adv. Immunol., 47: 187-376, 1989.
3. Siegel, J. P., Sharon, M., Smith, P. L., and Leonard, W. J. The IL-2-receptor beta chain (p70): role in mediating signals for LAK, NK and proliferative activities. Science (Washington DC), 238: 75-78, 1987.
4. Whiteside, T. L., and Herberman, R. B. Characteristics of natural killer cells and lymphokine-activated killer cells. Their role in the biology and treatment of human cancer. Immunol. Allergy Clin. North Am., 10: 663-704, 1990.
5. Vujanovic, N. L., Rabinowich, H., Lee. Y. J., Jost, L., Herberman, R. B., and Whiteside, T. L. Characteristics of human natural killer cells obtained by rapid interleukin 2-induced adherence to plastic. Cell. Immunol., 151: 133-157, 1993.
6. Sacchi, M., Vitolo, D., Sedlmayr, P., Rabinowich, H., Johnson, J. T., Herberman, R. B., and Whiteside, T. L. Induction of tumor regression in experimental model of human head and neck cancer by human A-LAK cells and IL-2. Int. J. Cancer, 47: 784-791, 1991.
7. Yasumura, S., Lin, W-c., Hirabayashi, H., Vujanovic, N. L., Herberman, R. B., and Whiteside, T. L. Immunotherapy of liver metastases of human gastric carcinoma with IL-2-activated natural killer cells. Cancer Res., 54: 3808-3816, 1994.
8. Vujanovic, N. L., Yasumura, S., Hirabayashi, H., Lin, W-c., Watkins, S., Herberman, R. B., and Whiteside, T. L. Antitumor activities of subsets of human IL-2-activated natural killer cells in solid tissues. J. Immunol., 154: 281-289, 1995.
9. Whiteside, T. L., Ernstoff, M. S., Nair, S., Kirkwood, J. M., and Herberman, R. B. In vitro generation and in vivo effects of adherentlymphokine activated killer (A-LAK) cells and IL-2 in patients with solid tumors. In: R. E. Schmidt (ed.), Natural Killer Cells: Biology and Clinical Application, pp. 293-302, 6th International NK Cell Workshop. Basel, Switzerland: S. Karger, 1990.
10. Lister, J., Rybka, W. B., Donnenberg, A. D., de Magalhaes-Silverman, M., Pincus, S. M., Bloom, E. J., Elder, E. M., Ball, E. D., and Whiteside, T. L. Autologous peripheral blood stem cell transplantation and adoptive immunotherapy with A-NK cells in the immediate posttransplant period. Clin. Cancer Res., 1: 607-614, 1995.
11. Vitolo, D., Vujanovic, N., Rabinowich, H., Schlesinger, M., Herberman, R. B., and Whiteside, T. L. Rapid interleukin-2 induced adherence of human natural killer (NK) cells accompanied by expression of mRNA for cytokines and IL-2 receptors. J. Immunol., 151: 1926-1937, 1993.
12. Basse, P., Herberman, R. B., Nannmark, U., Johansson, E. R., Hokland, M., Wasserman, K., and Goldfarb, R. Accumulation of adoptively transferred A-LAK cells in metastases. J. Exp. Med., 174: 479-488, 1991.
13. Traversari, C., van der Bruggen, P., Luesdier, J. F., Lurguin, C., Chanee, P., Van Pel, A., De Pleau, E., Amar-Costesec, A., and Boon, T. A nonapeptide encoded by human gene MAGE1 is recognized on HLA-A1 by CTL directed against tumor antigen M22-E. J. Exp. Med., 176: 1453-1457, 1992.
14. Whiteside, T. L., Chikamatsu, K., Nagashima, S., and Okada, K. Antitumor effects of cytolytic T lymphocytes (CTL) and natural killer (NK) cells in head and neck cancer. Anticancer Res., 16: 2357-2364, 1996.
15. Yasumura, S., Hirabayashi, H., Schwartz, D. R., Toso, J. F., Johnson, J. T., Herberman, R. B., and Whiteside, T. L. Human cytotoxic T-cell lines with restricted specificity for squamous cell carcinoma of the head and neck. Cancer Res., 53: 1461-1468, 1993.
16. Kawashiri, S., Kumagai, S., Kojima, K., Harada, H., and Yamamoto, E. Development of a new invasion and metastasis model of human oral squamous cell carcinomas. Oral Oncol., Eur. J. Cancer, 31B: 216-222, 1995.
17. De Bree, R., Roos, J. C., Quak, J. J., Den Hollander, W., Snow, G. B., and van Dongen, G. M. A. S. Clinical screening of MAbs 323/A3, CSF-25 and K928 for suitability of targeting tumors in the upper aerodigestive and respiratory tract. Nucl. Med. Commun., 15: 613-617, 1994.
18. Whiteside, T. L., Bryant, J., Day, R., and Herberman, R. B. Natural killer cytotoxicity in the diagnosis of immune dysfunction: criteria for a reproducible assay. J. Clin. Lab. Anal., 4: 102-114, 1990.
19. + T lymphocytes and human squamous cell carcinoma of the head and neck. Cell. Immunol., 177: 35-48, 1997.
20. Sung, M-W., Yasumura, S., Johnson, J. T., Van Dongen, G. A. M. S., and Whiteside, T. L. Natural killer (NK) cells as effectors of antibody-dependent cytotoxicity with chimeric antibodies reactive with human squamous cell carcinomas of the head and neck. Int. J. Cancer, 61: 1-9, 1995.
21. Heo, D. S., Park, J-G., Hata, K., Day, R., Herberman, R. B., and Whiteside, T. L. Evaluation of tetrazolium-based semi-automatic colorimetric assay for measurement of antitumor cytotoxicity. Cancer Res., 50: 3681-3690, 1990.
22. Matzinger, P. The Jam test. A simple assay for DNA fragmentation and cell death. J. Immunol. Methods, 145: 185-192, 1991.
23. Yasumura, S., Weidmann, E., Hirabayashi, H., Johnson, J. T., Herberman, R. B., and Whiteside, T. L. HLA restriction and T-cell receptor V8 gene expression of cytotoxic T lymphocytes reactive with human squamous cell carcinoma of the head and neck. Int. J. Cancer, 57: 297-305, 1994.
24. Wilson, B., Ozturk, M., Takahashi, H., Motte, P., Kew, M., Isselbacher, K. J., and Wands, J. R. Cell-surface changes associated with transformation of human heptocytes to the malignant phenotype. Proc. Natl. Acad. Sci., 85: 3140-3144, 1988.
25. Vujanovic, N. L., Nagashima, S., Herberman, R. H., and Whiteside, T. L. Non-secretory apoptotic killing by human natural killer cells. J. Immunol., 157: 1117-1126, 1996.
26. Kagi, D., Vignaux, F., Ledermann, D., Burri, K., Depraetere, V., Nagata, S., Hengartner, H., and Goldstein, P. Fas and perform pathways as major mechanisms of T cell-mediated cytotoxicity. Science (Washington DC), 265: 528-530, 1994.
27. Penza, R., Akella, V., and Lurquin, P. F. DiI as a marker for cellular transplantation into solid organs. Biotechniques, 13: 581-587, 1992.
28. Burnet, F. M. Cancer: a biologic approach. Br. Med. J., 1: 771-849, 1957.
29. Burnet, F. M. The concept of immunological surveillance. Prog. Exp. Tumor Res., 13: 1-27, 1970.
30. Thomas, L. Discussion. In: Lawrence, H. S. (ed.), Cellular and Humoral Aspects of the Hypersensitive State, pp. 529-532. New York: Hoeber, 1959.
31. Whiteside, T. L., and Herberman, R. B. Role of natural killer cells in immune surveillance of cancer. Curr. Opin. Immunol., 7: 704-710. 1995.
32. Gorelik, E., and Herberman, R. B. Role of natural killer (NK) cells in the control of tumor growth and metastatic spread. In: R. B. Herberman (ed.), Cancer Immunology: Innovative Approaches to Therapy, pp. 151-176. New York: Martius Nijhoft Press, 1986.
33. Finn, O. J. Tumor-rejection antigens recognized by lymphocytes. Curr. Opin. Immunol., 5: 701-708, 1993.
34. Whiteside, T. L. Tumor-Infiltrating Lymphocytes in Human Malignancies. Austin, TX: R. G. Landes Co., 1993.
35. Ortaldo., J. R., Mason, A., and Overton, R. Lymphokine-activated killer cells: analysis of progenitors and effectors. J. Exp. Med., 164: 1193-1205, 1986.
36. Carey, T. E. Establishment of epidermoid carcinoma cell lines. In: R. E. Wittes (ed.), Head and Neck Cancer, pp. 287-314, London: Wiley & Sons, 1985.
37. Berke, G. The binding and lysis of target cells by cytotoxic lymphocytes: molecular and cellular aspects. Annu. Rev. Immunol., 12: 735-774, 1994.
38. Arase, H., Arase, N., and Saito, T. Fas-mediated cytotoxicity by freshly isolated natural killer cells. J. Exp. Med., 181: 1235-1238, 1995.
39. Hata, K., Van Thiel, D. H., Herberman, R. B., and Whiteside, T. L. Natural killer activity of human liver-derived lymphocytes in various hepatic diseases. Hepatology, 14: 495-503, 1991.